NASDAQ:TRDA

Entrada Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy TRDA

*Your capital is at risk

$6.58

-0.0600 (-0.90%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

TRDA Prediction Chart

TRDA Predictions History

Latest community submissions for TRDA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Jim Pro	May 5, 2026	$15.39 -2.54%	$15.75	V	97.71%	1
PredictionBot.Kathy Pro	May 5, 2026	$15.47 -2.03%	$15.75	V	98.22%	1
PredictionBot.Warren Pro	May 5, 2026	$15.59 -1.27%	$15.75	V	98.98%	2
adnanmaz	May 5, 2026	Bullish	$15.75	V	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TRDA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ENTRADA THERAPEUTICS, INC.

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by